IRIS PubliCatt

Cauda, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.791
NA - Nord America 11.463
AS - Asia 3.366
AF - Africa 50
SA - Sud America 48
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 20
Totale 27.762
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.365
DE - Germania 4.307
CN - Cina 2.283
SE - Svezia 2.078
IT - Italia 1.416
PL - Polonia 1.128
UA - Ucraina 1.123
FR - Francia 910
IE - Irlanda 590
GB - Regno Unito 434
SG - Singapore 396
FI - Finlandia 287
IN - India 259
RU - Federazione Russa 248
TR - Turchia 247
BE - Belgio 74
IR - Iran 52
CA - Canada 49
NL - Olanda 42
JP - Giappone 40
HK - Hong Kong 38
AT - Austria 35
MX - Messico 31
CI - Costa d'Avorio 22
EU - Europa 22
BR - Brasile 21
CH - Svizzera 20
AU - Australia 18
VN - Vietnam 14
BZ - Belize 13
CZ - Repubblica Ceca 13
ES - Italia 13
CO - Colombia 9
GR - Grecia 9
EG - Egitto 8
RO - Romania 8
BG - Bulgaria 7
MA - Marocco 7
PT - Portogallo 7
AR - Argentina 6
KR - Corea 6
MY - Malesia 6
AL - Albania 5
DK - Danimarca 5
HU - Ungheria 5
PH - Filippine 5
VA - Santa Sede (Città del Vaticano) 5
CL - Cile 4
EC - Ecuador 4
NG - Nigeria 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
ID - Indonesia 3
LT - Lituania 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
PA - Panama 3
BN - Brunei Darussalam 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
KE - Kenya 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PE - Perù 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BO - Bolivia 1
CY - Cipro 1
GA - Gabon 1
GL - Groenlandia 1
IQ - Iraq 1
IS - Islanda 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VE - Venezuela 1
Totale 27.762
Salva come PNG Salva come JPEG
Città #
Chandler 2.407
Ashburn 902
Jacksonville 750
Hangzhou 628
Warsaw 582
Dublin 581
San Mateo 567
Kraków 542
Nanjing 432
Ann Arbor 394
New York 385
Dearborn 353
Wilmington 340
Houston 310
Woodbridge 308
Nürnberg 294
Singapore 246
Izmir 226
Boston 219
Milan 212
Redmond 185
Lawrence 184
Fairfield 181
Cattolica 179
Moscow 178
Nanchang 173
Beijing 172
Seattle 164
Marseille 151
Princeton 151
Rome 145
Redwood City 135
Lancaster 120
Bremen 109
Shenyang 101
Boardman 100
Kunming 89
Munich 87
Mountain View 74
Hebei 73
Norwalk 71
Brussels 68
Los Angeles 64
University Park 63
Cambridge 62
Tianjin 61
Fremont 59
Chicago 58
Changsha 54
Leawood 53
Jiaxing 48
Augusta 44
Zhengzhou 44
Pune 42
Guangzhou 38
Jinan 37
Shanghai 37
Helsinki 36
Verona 36
San Jose 34
Hong Kong 33
Simi Valley 32
Vienna 31
Washington 31
Philadelphia 25
Hefei 24
Abidjan 22
Kish 21
Buffalo 20
Falls Church 20
London 20
Andover 19
Edinburgh 19
Ottawa 19
Amsterdam 17
Changchun 17
Lanzhou 17
Auburn Hills 15
Detroit 15
Ningbo 15
Toronto 14
Belize City 13
Fuzhou 13
Phoenix 13
Tokyo 13
Las Vegas 12
Busto Arsizio 11
Cuauhtémoc 11
Costa Mesa 10
São Paulo 10
Bari 9
Springfield 9
Taizhou 9
Viterbo 9
Chengdu 8
Indiana 8
Modena 8
Naples 8
Phoenixville 8
Tappahannock 8
Totale 15.074
Salva come PNG Salva come JPEG
Nome #
New classification for the treatment of pyogenic spondylodiscitis: validation study on a population of 250 patients with a follow-up of 2 years 340
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 330
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 317
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 308
Factors associated with mortality in bacteremic patients with haematologic malignancies 295
Factors associated with mortality in bacteremic patients with hematologic malignancies. 295
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 294
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 274
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 254
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 215
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 211
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 204
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 193
La pandemia di COVID-19: un limite o una frontiera per la Legge 24/2017? 191
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 188
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 172
Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility 172
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 168
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 166
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 161
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 159
Factors associated with mortality in bacteremic patients with hematologic malignancies. 159
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 158
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 155
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 147
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 145
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 145
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 145
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 143
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 138
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 138
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 135
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 134
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 134
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 132
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 130
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 130
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 127
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 127
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 124
Variability of raltegravir plasma levels in the clinical setting 123
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 122
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 120
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 119
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 119
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 119
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 118
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 117
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 116
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 116
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 115
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 115
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 113
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 113
Testimonianze dalle periferie del mondo. Sei anni di Charity Work Program Quaderni del CeSI Edizione Vita e Pensiero . 111
Attitudes and practices of dentists treating HIV patients in HAART era. 110
Prospective evaluation of epidemiological, clinical, and microbiological features of pandemic influenza A (H1N1) virus infection in Italy 109
The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study 107
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 105
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 105
Initial antifungal strategy does not correlate with mortality in patients with candidemia 105
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 104
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 104
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 103
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 103
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients, a systematic review and meta-analysis 103
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 102
Cardiovascular risk factors and carotid intima-media thickness are associated with low cognitive performance in HIV-infected patients 102
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 102
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer's disease, and Parkinson's disease: An evaluation of the "cortical hypothesis" of NeuroAIDS 102
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 102
Clinical presentation, microbiological features and correlates of disease severity of 2009 pandemic influenza A (H1N1) infection 101
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 101
Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis 101
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 100
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 100
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 99
Comparison of expression vectors in Lactobacillus reuteri strains 98
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 98
Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure. 97
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 97
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 96
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 96
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 96
Effect of aging and human immunodeficiency virus infection on cognitive abilities 96
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 96
HIV-infected patients show impaired cellular immune response to influenza vaccination, compared to healthy subjects 96
Effects of antiretroviral therapy on tube-like network formation of human endothelial cells. 95
Resource-saving advice from an infectious diseases specialist team in a large university hospital: an exportable model? 95
Cognitive reserve and neuropsychological functioning in older HIV-infected people 95
Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1 94
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 94
Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction? 93
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 93
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop 93
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 93
Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections 93
Impact of antibiotic stewardship on perioperative antimicrobial prophylaxis 93
Totale 13.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.266 0 238 264 263 335 418 357 167 287 250 344 343
2020/20212.714 214 291 70 268 330 173 285 61 408 124 429 61
2021/20223.152 258 257 85 240 133 109 70 516 126 222 482 654
2022/20236.582 834 942 538 960 515 740 280 521 836 122 208 86
2023/20243.125 137 875 97 246 128 517 186 97 49 104 360 329
2024/2025194 135 59 0 0 0 0 0 0 0 0 0 0
Totale 28.130